In a recent study published in the journal Eurosurveillance, researchers investigated the unusual rise in emergency department (ED) visits for pneumonia among children aged 5–14 years in England since November 2023.
Their findings indicate that this increase, which persisted into early summer 2024, was primarily driven by the bacteria Mycoplasma pneumoniae (MP), even as other seasonal respiratory infections decreased.
Background
Respiratory infections during the winter often burden healthcare services in the UK. The UK Health Security Agency (UKHSA) manages a surveillance program that tracks and reports respiratory illnesses yearly to help understand and manage their impact.
Recently, an unusual rise in pneumonia cases among children between the ages of 5 and 14 was detected through the program, leading to an investigation to understand what was causing this unexpected increase.
About the study
The UKHSA’s program monitors respiratory infections through various systems, including lab reports, general practice data, and real-time tracking of ED visits.
The surveillance program includes data from primary care physicians, laboratory reports, hospital admissions, ED attendance, and telehealth calls, monitoring a range of respiratory indicators from the milder common colds, which are self-limiting, to more severe illnesses like pneumonia.
This monitoring helps identify mild and severe respiratory illnesses and their effects on the healthcare system, particularly during the high-demand winter months.
Findings
Beginning in November 2023, the number of children between the ages of 5 and 14 visiting EDs for pneumonia began to rise above historical expectations, as observed through the UKHSA’s syndromic surveillance system.
This elevated activity continued through December 2023 and did not follow the typical seasonal decline in January 2024. Instead, the higher-than-expected number of pneumonia-related ED visits persisted between February and July 2024.
During this period, 2,532 pneumonia-related ED visits were recorded in this age group, which, while lower than the 45,003 cases reported in individuals aged 15 years and older, was still significantly higher than in previous years.
For context, the average number of visits during the same period of 2019-20 and 2022-23 for this age group were, respectively, 607 and 818, highlighting a notable surge in 2024.
Further analysis using data from the Emergency Care Dataset (ECDS) and linked laboratory reports confirmed that, between November 2022 and May 2024, there were 14,096 pneumonia-related ED attendances, with 2,334 of these linked to positive microbiology results.
Among the pathogens identified, Respiratory Syncytial Virus (RSV) accounted for 16.6% of cases, influenza A virus for 9.8%, and MP for 9.3%.
While RSV and influenza followed their usual seasonal patterns, MP showed a marked increase in early 2024, particularly among children aged 5–14, where it was found in 32.2% of pneumonia cases.
Additionally, increasing trends in MP infections were observed in children between the ages of 1 and 4, suggesting a broader impact across younger age groups.
Conclusions
The study found a persistent increase in emergency department visits for pneumonia among children between the ages of 5 and 14, primarily due to an unusual rise in MP infections during the winter of 2023-24, the first significant MP epidemic after the coronavirus disease 2019 (COVID-19) pandemic.
MP is a common cause of bacterial pneumonia among school-going children, and while infections are usually mild, some can lead to severe illness.
The study highlights the importance of real-time syndromic surveillance, which enabled early detection of this trend and timely public health responses. England’s 2023-24 MP epidemic was part of a global increase in MP cases, but the unusually prolonged season was notable.
The reasons for this prolonged activity remain unclear, but it might be linked to changes in disease transmission patterns due to pandemic-related public health measures.
In conclusion, the study underscores the value of the UK Health Security Agency’s (UKHSA) comprehensive respiratory surveillance program, which includes real-time syndromic surveillance to detect and quickly investigate unusual patterns of illness.
The findings also indicate the need for further research to better understand MP and its impact on public health.
- Persistent elevation in incidence of pneumonia in children in England, 2023/24. Todkill, D., Lamagni, T., Pebody, R., Ramsay, M., Woolham, D., Demirjian, A., Salzmann, A., Chand, M., Hughes, H.E., Bennett, C., Hope, R., Watson, C.H., Brown, C.S., Elliot, A.J. Eurosurveillance (2024). DOI: 10.2807/1560-7917.ES.2024.29.32.2400485, https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.32.2400485
News
GLP-1 Drugs Like Ozempic Work, but New Research Reveals a Major Catch
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded studies raise concerns. Three new reviews from Cochrane have found that GLP-1 medications can lead to significant [...]
How a Palm-Sized Laser Could Change Medicine and Manufacturing
Researchers have developed an innovative and versatile system designed for a new generation of short-pulse lasers. Lasers that produce extremely short bursts of light are known for their remarkable precision, making them indispensable tools [...]
New nanoparticles stimulate the immune system to attack ovarian tumors
Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian [...]
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
